Vident Advisory, LLC Gilead Sciences, Inc. Transaction History
Vident Advisory, LLC
- $6.84 Trillion
- Q1 2025
A detailed history of Vident Advisory, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 39,507 shares of GILD stock, worth $4.37 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
39,507
Previous 25,828
52.96%
Holding current value
$4.37 Million
Previous $2.39 Billion
85.55%
% of portfolio
0.06%
Previous 0.04%
Shares
8 transactions
Others Institutions Holding GILD
# of Institutions
2,289Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.59 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.04 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.93 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $139B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...